Predictive cheminformatics in drug discovery: Statistical modeling for analysis of micro-array and gene expression data

Methods in Molecular Biology

Volumn 910, Issue , 2012, Pages 165-194

  Sukumar, N ^a   Krein, Michael P ^a   Embrechts, Mark J ^b  

^a Research Rensselaer Polytechnic Institute   (United States)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Bioinformatics; Cheminformatics; Data mining; High throughput screening; Micro array; Molecular modeling; Molecular similarity; QSAR

Indexed keywords

ARTICLE; BIOLOGY; CHEMICAL DATABASE; DRUG DEVELOPMENT; GENE EXPRESSION PROFILING; METHODOLOGY; MICROARRAY ANALYSIS; STATISTICAL MODEL; STRUCTURE ACTIVITY RELATION;

COMPUTATIONAL BIOLOGY; DATABASES, CHEMICAL; DRUG DISCOVERY; GENE EXPRESSION PROFILING; MICROARRAY ANALYSIS; MODELS, STATISTICAL; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84864837998     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-965-5_9     Document Type: Article

References (145)

1. Sukumar N, Krein M, Breneman CM (2008) Bio-and Chem-Informatics: where do the twain meet? Curr Opin Drug Discov Dev 11:311-319 (Pubitemid 351572440)
2. Good BM, Wilkinson MD (2006) The life sciences semantic web is full of creeps. Brief Bioinform 7:275-286 (Pubitemid 44417949)
3. Zimmermann M, Fluck J, Thi LTB et al (2005) Information extraction in the life sciences: perspectives for Med. Chem., pharmacology and toxicology. Curr Top Med Chem 5:785-796
4. Stevens R, Goble CA, Bechhofer S (2000) Ontology-based knowledge representation for bioinformatics. Brief Bioinform 1:398-414
5. Ashburner M, Ball CA, Blake JA et al (2000) Gene ontology: tool for the uni fi cation of biology. The Gene Ontology Consortium. Nat Genet 25:25-29 (Pubitemid 30257031)
6. Karp PD (2000) An ontology for biological function based on molecular interactions. Bioinformatics 16:269-285 (Pubitemid 30352854)
7. Schuffenhauer A, Zimmermann J, Stoop R et al (2002) An ontology for pharmaceutical ligands and its application for in silico screening and library design. J Chem Inf Comput Sci 42:947-955 (Pubitemid 35355244)
8. Schuffenhauer A, Jacoby E (2004) Annotating and mining the ligand-target chemogenomics knowledge space. Drug Discov Today 2:190-200 (Pubitemid 39349125)
9. Bodenreider O, Stevens R (2007) Bioontologies: current trends and future directions. Brief Bioinform 7:256-274.
10. Paolini GV, Shapland RHB, Hoorn WPv et al (2006) Global mapping of pharmacological space. Nat Biotechnol 24:805-815. (Pubitemid 44086621)
11. Cronin MTD, Schultz TW (2003) Pitfalls in QSAR. J Mol Struct (Theochem) 622:39-51.
12. Scior T, Medina-Franco JL, Do QT et al (2009) How to recognize and workaround pitfalls in QSAR studies: a critical review. Curr Med Chem 16:4297-4313.
13. Zvinavashe E, Murk AJ, Rietjens IMCM (2008) Promises and pitfalls of quantitative structure-activity relationship approaches for predicting metabolism and toxicity. Chem Res Toxicol 21:2229-2236.
14. Verma RP, Hansch C (2005) An approach toward the problem of outliers in QSAR. Bioorg Med Chem 13:4597-4621. (Pubitemid 40848339)
15. Maggiora GM (2006) On outliers and activity cliffs-why QSAR often disappoints. J Chem Inf Model 46:1535. (Pubitemid 44185680)
16. Casalegno M, Sello G, Benfenati E (2008) De fi nition and detection of outliers in chemical space. J Chem Inf Model 48:1592-1601.
17. Guha R, Schürer S (2008) Utilizing high throughput screening data for predictive toxicology models: protocols and application to MLSCN assays. J Comput Aided Mol Des 22:367-384.
18. Jaworska J, Nikolova-Jeliazkova N, Aldenberg T (2005) QSAR applicability domain estimation by projection of the training set in descriptor space: a review. Altern Lab Anim 33:445-459. (Pubitemid 41613738)
19. Dimitrov S, Dimitrova G, Pavlov T et al (2005) A stepwise approach for de fi ning the applicability domain of SAR and QSAR models. J Chem Inf Model 45:839-849. (Pubitemid 41156682)
20. Golbraikh A, Tropsha A (2002) Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. J Comput Aided Mol Des 16:357-369. (Pubitemid 35414668)
21. Dearden JC, Cronin MTD, Kaiser KLE (2009) How not to develop a quantitative structure-activity or structure-property relationship (QSAR/QSPR). SAR QSAR Environ Res 20:241-266.
22. Wold S, Dunn WJ (1983) Multivariate quantitative structure-activity relationships (QSAR): conditions for their applicability. J Chem Inf Comput Sci 23:6-13.
23. Wold S, Ruhe A, Wold H et al (1984) The collinearity problem in linear regression. The Partial Least Squares (PLS) approach to generalized inverses. SIAM J Sci Stat Comput 5:735.
24. Tropsha A, Gramatica P, Gombar VK (2003) The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. QSAR Comb Sci 22:69-77. (Pubitemid 36717473)
25. Gramatica P (2007) Principles of QSAR models validation: internal and external. QSAR Comb Sci 26:694-701. (Pubitemid 46932857)
26. Golbraikh A, Tropsha A (2002) Beware of q2. J Mol Graph Model 20:269-276.
27. Cramer RD, Bunce JD, Patterson DE et al (1988) Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. QSAR 7:18-25.
28. Liu H, Papa E, Gramatica P (2006) QSAR prediction of estrogen activity for a large set of diverse chemicals under the guidance of OECD principles. Chem Res Toxicol 19:1540-1548. (Pubitemid 44863497)
29. Tropsha A (2010) Best practices for QSAR model development, validation, and exploitation. Mol Inf 29:476-488.
30. Rücker C, Rücker G, Meringer M (2007) y-Randomization and its variants in QSPR/QSAR. J Chem Inf Model 47:2345-2357. (Pubitemid 350284525)
31. Weininger D (1988) SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J Chem Inf Comput Sci 28:31-36. (Pubitemid 18574254)
32. Lipinski CA, Lombardo F, Dominy BW et al (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3-25. (Pubitemid 27046991)
33. Sigrist CJA, Cerutti L, Hulo N et al (2002) PROSITE: a documented database using patterns and pro fi les as motif descriptors. Brief Bioinform 3:265-274.
34. Suzuki M (1994) A framework for the DNA-protein recognition code of the probe helix in transcription factors: the chemical and stereochemical rules. Structure 2:317-326.
35. Suzuki M, Yagi N (1994) DNA recognition code of transcription factors in the helix-turnhelix, probe helix, hormone receptor and zinc fi nger families. Proc Natl Acad Sci USA 91:12357-12361.
36. Mandel-Gutfreund Y, Margalit H (1998) Quantitative parameters for amino acid-base interaction: implications for prediction of protein-DNA binding sites. Nucleic Acids Res 26:2306-2312. (Pubitemid 28297328)
37. Rao JKM (1987) New scoring matrix for amino acid residue exchanges based on residue characteristic physical parameters. Int J Pept Protein Res 29:276-281.
38. Grantham R (1974) Amino acid difference formula to help explain protein evolution. Science 185:862-864.
39. Dayhoff MO (1978) Atlas of protein sequence and structure. National Biomedical Research Foundation, Silver Spring, MD
40. Nakai K, Kidera A, Kanehisa M (1988) Cluster analysis of amino acid indices for prediction of protein structure and function. Protein Eng 2:93-100.
41. Tomii K, Kanehisa M (1996) Analysis of amino acid indices and mutation matrices for sequence comparison and structure prediction of proteins. Protein Eng 9:27-36. (Pubitemid 26099761)
42. Tung C-W, Ho S-Y (2007) POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties. Bioinformatics 23:942-949. (Pubitemid 47050580)
43. Rausch C, Weber T, Kohlbacher O et al (2005) Speci fi city prediction of adenylation domains in nonribosomal peptide synthetases (NRPS) using transductive support vector machines (TSVMs). Nucleic Acids Res 33:5799-5808. (Pubitemid 41742599)
44. Sarda D, Chua GH, Li K-B et al (2005) pSLIP: SVM based protein subcellular localization prediction using multiple physicochemical properties. BMC Bioinform 6:152.
45. Mundra P, Kumar M, Kumar KK et al (2007) Using pseudo amino acid composition to predict protein subnuclear localization: approached with PSSM. Pattern Recognit Lett 28:1610-1615. (Pubitemid 47058614)
46. Afonnikov DA, Kolchanov NA (2004) CRASP: a program for analysis of coordinated substitutions in multiple alignments of protein sequences. Nucleic Acids Res 32:W64-W68. (Pubitemid 38997302)
47. Liu B, Li S, Wang Y et al (2007) Predicting the protein SUMO modi fi cation sites based on Properties Sequential Forward Selection (PSFS). Biochem Biophys Res Commun 358:136-139. (Pubitemid 46719092)
48. Bannai H, Tamada Y, Maruyama O et al (2002) Extensive feature detection of N-terminal protein sorting signals. Bioinformatics 18:298-305. (Pubitemid 34183107)
49. Dubchak I, Muchnick I, Mayor C et al (1999) Recognition of a protein fold in the context of the Structural Classi fi cation of Proteins (SCOP) classi fi cation. Proteins 35:401-407. (Pubitemid 29264836)
50. Dubchak I, Muchnik I, Holbrook SR et al (1995) Prediction of protein folding class using global description of amino acid sequence. Proc Natl Acad Sci USA 92:8700-8704
51. Cai CZ, Han LY, Ji ZL et al (2003) SVM-Prot: web-based support vector machine software for functional classi fi cation of a protein from its primary sequence. Nucleic Acids Res 31:3692-3697. (Pubitemid 37442225)
52. Cai YD, Liu XJ, Xu XB et al (2002) Support vector machines for predicting HIV protease cleavage sites in protein. J Comput Chem 23:267-274.
53. Gao Q-B, Wang Z-Z, Yan C et al (2005) Prediction of protein subcellular location using a combined feature of sequence. FEBS Lett 579:3444.
54. Grant JA, Haigh JA, Pickup BT et al (2006) Lingos, fi nite state machines and fast similarity searching. J Chem Inf Model 46: 1912-1918. (Pubitemid 44625962)
55. Melville JL, Riley JF, Hirst JD (2007) Similarity by compression. J Chem Inf Model 47:25-33. (Pubitemid 46225556)
56. Randic M (2001) The connectivity index 25 years after. J Mol Graph Model 20:19-35.
57. Rupp M, Proschak E, Schneider G (2007) Kernel approach to molecular similarity based on iterative graph similarity. J Chem Inf Model 47:2280-2286. (Pubitemid 350275094)
58. Lin Z, Pan XM (2001) Accurate prediction of protein secondary structural content. J Protein Chem 20:217-220.
59. Chou KC, Cai YD (2005) Prediction of membrane protein types by incorporating amphipathic effects. J Chem Inf Model 45:407-413.
60. Bergeron C, Hepburn T, Sundling M et al. Prediction of peptide bonding af fi nity: kernel methods for nonlinear modeling. http://arxiv.org/abs/1108. 5397v1.
61. Song M, Breneman CM, Bi J et al (2002) Prediction of protein retention times in anionexchange chromatography systems using support vector regression. J Chem Inf Comput Sci 42:1347-1357. (Pubitemid 35468322)
62. Mazza CB, Sukumar N, Breneman CM et al (2001) Prediction of protein retention in ionexchange systems using molecular descriptors obtained from crystal structure. Anal Chem 73:5457-5461. (Pubitemid 33108555)
63. Schneider G, Wrede P (1994) The rational design of amino acid sequences by arti fi cial neural networks and simulated molecular evolution: de novo design of an idealized leader peptidase cleavage site. Biophys J 66:335-344. (Pubitemid 24058452)
64. Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular fi eld analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959-5967.
65. Rush TS, Grant JA, Mosyak L et al (2005) A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. J Med Chem 48:1489-1495. (Pubitemid 40364556)
66. Masek BB, Merchant A, Matthew JB (1993) Molecular shape comparison of angiotensin II receptor antagonists. J Med Chem 36:1230-1238. (Pubitemid 23159297)
67. Wagener M, Sadowski J, Gasteiger J (1995) Autocorrelation of molecular surface properties for modeling corticosteroid binding globulin and cytosolic Ah receptor activity by neural networks. J Am Chem Soc 117:7769-7775.
68. Ballester PJ, Richards WG (2007) Ultrafast shape recognition to search compound databases for similar molecular shapes. J Comput Chem 28:1711-1723. (Pubitemid 47146547)
69. Ballester PJ, Richards WG (2007) Ultrafast shape recognition for similarity search in molecular databases. Proc R Soc A 463: 1307-1321.
70. Breneman CM, Sundling CM, Sukumar N et al (2003) New developments in PEST shape/property hybrid descriptors. J Comput Aided Mol Des 17:231-240. (Pubitemid 37062784)
71. Nagarajan K, Zauhar R, Welsh WJ (2005) Enrichment of ligands for the serotonin receptor using the shape signatures approach. J Chem Inf Model 45:49-57. (Pubitemid 40736955)
72. Zauhar RJ, Moyna G, Tian L et al (2003) Shape signatures, a new approach to computer-aided ligand-and receptor-based drug design. J Med Chem 46:5674-5690. (Pubitemid 37543318)
73. Pastor M, Cruciani G, McLay I et al (2000) GRid-INdependent Descriptors (GRIND): a novel class of alignment-independent threedimensional molecular descriptors. J Med Chem 43:3233-3243.
74. Clark T (2004) QSAR and QSPR based solely on surface properties? J Mol Graph Model 22:519-525. (Pubitemid 38746577)
75. Ehresmann B, Groot MJd, Alex A et al (2004) New molecular descriptors based on local properties at the molecular surface and a boiling-point model derived from them. J Chem Inf Comput Sci 44:658-668.
76. Ballester PJ, Finn PW, Richards WG (2009) Ultrafast shape recognition: evaluating a new ligand-based virtual screening technology. J Mol Graph Model 27:836-845.
77. Steffen NR, Murphy SD, Tolleri L et al (2002) DNA sequence and structure: direct and indirect recognition in protein-DNA binding. Bioinformatics 18:22-30.
78. Aida M (1998) An ab-initio molecular orbital study on the sequence-dependency of DNAconformation: an evaluation of intra-and inter-strand stacking interaction energy. J Theor Biol 130:327-335.
79. Kono H, Sarai A (1999) Structure-based prediction of DNA target sites by regulatory proteins. Proteins 35:114-131. (Pubitemid 29128158)
80. Pichierri F, Aida M, Gromiha MM et al (1999) Free-energy maps of base-amino acid interactions for DNA-protein recognition. J Am Chem Soc 121:6152-6157.
81. Liu R, Blackwell TW, States DJ (2001) Conformational model for binding site recognition by the E. coli MetJ transcription factor. Bioinformatics 17:622-633.
82. Whitehead CE, Breneman CM, Sukumar N et al (2003) Transferable atom equivalent multi-centered multipole expansion method. J Comput Chem 24:512-529.
83. Sukumar N, Breneman CM (2007) QTAIM in drug discovery and protein modeling. In: Matta CF, Boyd RJ (eds) The quantum theory of atoms in molecules: from solid state to DNA and drug design. Wiley-VCH, Weinheim, pp 471-498.
84. Johnson MA, Maggiora GM (1990) Concepts and applications of molecular similarity. Wiley, New York, NY
85. Martin YC, Kofron JL, Traphagen LM (2002) Do structurally similar molecules have similar biological activity? J Med Chem 45:4350-4358. (Pubitemid 35025581)
86. Guha R, Van Drie JH (2008) Structure-activity landscape index: identifying and quantifying activity cliffs. J Chem Inf Model 48:646-658. (Pubitemid 351535432)
87. Peltason L, Bajorath J (2007) SAR index: quantifying the nature of structure-activity relationships. J Med Chem 50:5571-5578. (Pubitemid 350106013)
88. Peltason L, Iyer P, Bajorath J (2010) Rationalizing three-dimensional activity landscapes and the in fl uence of molecular representations on landscape topology and the formation of activity cliffs. J Chem Inf Model 50:1021-1033.
89. Bajorath J, Peltason L, Wawer M et al (2009) Navigating structure-activity landscapes. Drug Discov Today 14:698-705.
90. Bredel M, Jacoby E (2004) Chemogenomics: an emerging strategy for rapid target and drug discovery. Nat Rev Genet 5:262-275. (Pubitemid 38435622)
91. Mestres J (2004) Computational chemogenomics approaches to systematic knowledgebased drug discovery. Curr Opin Drug Discov Dev 7:304-313. (Pubitemid 44120947)
92. Klabunde T (2007) Chemogenomic approaches to drug discovery: similar receptors bind similar ligands. Br J Pharmacol 152:5-7. (Pubitemid 47339899)
93. Rognan D (2007) Chemogenomic approaches to rational drug design. Br J Pharmacol 152:38-52. (Pubitemid 47339898)
94. Oloff S, Zhang S, Sukumar N et al (2006) Chemometric analysis of ligand receptor complementarity: identifying Complementary Ligands Based on Receptor Information (CoLiBRI). J Chem Inf Model 46:844-851.
95. Xie L, Bourne PE (2008) Detecting evolutionary relationships across existing fold space, using sequence order-independent pro fi le-pro fi le alignments. Proc Natl Acad Sci USA 105:5441-5446. (Pubitemid 351753882)
96. Ren J, Xie L, Li WW et al (2010) SMAP-WS: a parallel web service for structural proteomewide ligand-binding site comparison. Nucleic Acids Res 38:W441-W444.
97. Kinnings SL, Liu N, Buchmeier N et al (2009) Drug discovery using chemical systems biology: repositioning the safe medicine comtan to treat multi-drug and extensively drug resistant tuberculosis. PLoS Comput Biol 5:e1000423.
98. Das S, Krein MP, Breneman CM (2010) Binding af fi nity prediction with propertyencoded shape distribution signatures. J Chem Inf Model 50:298-308.
99. Milletti F, Vulpetti A (2010) Predicting polypharmacology by binding site similarity: from kinases to the protein universe. J Chem Inf Model 50:1418-1431
100. Chen B, Wild DJ (2010) PubChem BioAssays as a data source for predictive models. J Mol Graph Model 28:420-426
101. Hopkins AL (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4:682-690
102. Wawer M, Peltason L, Weskamp N et al (2008) Structure-activity relationship anatomy by network-like similarity graphs and local structure-activity relationship indices. J Med Chem 51:6075-6084
103. Fliri AF, Loging WT, Thadeio PF et al (2005) Biological spectra analysis: linking biological activity pro fi les to molecular structure. Proc Nat Acad Sci USA 102:261-266 (Pubitemid 40116755)
104. Kauvar LM, Higgins DL, Villar HO et al (1995) Predicting ligand binding to proteins by af fi nity fi ngerprinting. Chem Biol 2:107-118
105. Krejsa C, Horvath D, Rogalski S et al (2003) Predicting ADME properties and side effects: the BioPrint approach. Curr Opin Drug Discov Dev 6:470-480 (Pubitemid 36975350)
106. Stanforth RW, Kolossov E, Mirkin B (2007) A measure of domain of applicability for QSAR modelling based on intelligent K-means clustering. QSAR Comb Sci 26:837-844 (Pubitemid 47121260)
107. Kerzic D, Blazic BJ, Batagelj V (1994) Comparison of three different approaches to the property prediction problem. J Chem Inf Comput Sci 34:391-394
108. Bennett K, Demiriz A, Embrechts M (1999) Semi-supervised clustering using genetic algorithms. Artif Neural Networks Eng 14:809-814 (Pubitemid 30523784)
109. Rose VS, Croall IF, Mac fi e HJH (1991) An application of unsupervised neural network methodology kohonen topology-preserving mapping to QSAR analysis. QSAR 10:6-15
110. Eriksson L, Andersson P, Johansson E et al (2006) Megavariate analysis of environmental QSAR data. Part I: A basic framework founded on principal component analysis (PCA), partial least squares (PLS), and statistical molecular design (SMD). Mol Divers 10:169-186 (Pubitemid 44092207)
111. Guha R (2008) On the interpretation and interpretability of quantitative structure-activity relationship models. J Comput Aided Mol Des 22:857-871
112. Topliss JG, Edwards RP (1979) Chance factors in studies of quantitative-structure property relationships. J Med Chem 22:1238-1244 (Pubitemid 10237430)
113. Hoskuldson A (1988) PLS regression methods. J Chemometrics 2:211
114. Geladi P (1988) Notes on the history and nature of Partial Least-Squares (PLS) modelling. J Chemometrics 2:231
115. Golub TR, Slonim DK, Tamayo P et al (1999) Molecular classi fi cation of cancer: class discovery and class prediction by gene expression monitoring. Science 286:531-537
116. King R, Hirst J, Sternberg M (1993) New approaches to QSAR: neural networks and machine learning. Perspect Drug Discov Des 1:279-290
117. Huuskonen J, Salo M, Taskinen J et al (1997) Neural network modeling for estimation of the aqueous solubility of structurally related drugs. J Pharm Sci 86:450-454 (Pubitemid 27154760)
118. Livingstone DJ, Manallack DT, Tetko IV (1997) Data modelling with neural networks: advantages and limitations. J Comput Aided Mol Des 11:135-142 (Pubitemid 127508824)
119. Bruce CL, Melville JL, Pickett SD et al (2007) Contemporary QSAR classi fi ers compared. J Chem Inf Model 47:219-227 (Pubitemid 46225577)
120. Myles AJ, Feudale RN, Liu Y et al (2004) An introduction to decision tree modeling. J Chemometrics 18:275-285
121. Carvalho DR, Freitas AA (2004) A hybrid decision tree/genetic algorithm method for data mining. Inf Sci 163:13-35
122. Dudek AZ, Arodz T, Galvez J (2006) Computational methods in developing Quantitative Structure-Activity Relationships (QSAR): a review. Comb Chem High Throughput Screen 9:213-228
123. Hou T, Wang J, Zhang W et al (2006) ADME evaluation in drug discovery. 7. Prediction of oral absorption by correlation and classi fi cation. J Chem Inf Model 47:208-218 (Pubitemid 46225576)
124. Breiman L (2001) Random forests. Mach Learn 45:5-32 (Pubitemid 32933532)
125. Svetnik V, Liaw A, Tong C et al (2003) Random forest: a classi fi cation and regression tool for compound classi fi cation and QSAR modeling. J Chem Inf Comput Sci 43:1947-1958
126. Tong W, Hong H, Fang H et al (2003) Decision forest: combining the predictions of multiple independent decision tree models. J Chem Inf Comput Sci 43:525-531
127. Cortes C, Vapnik V (1995) Support-vector networks. Mach Learn 20:273-297
128. Scholkopf B, Smola AJ, Williamson RC et al (2000) New support vector algorithms. Neural Comput 12:1207-1245
129. Rosipal R, Trejo LJ (2001) Kernel partial least squares regression in reproducing kernel Hilbert space. Mach Learn Res 2:97-123
130. Bennett K, Campbell C (2000) Support vector machines: hype or hallelujah. SIGKDD Explor 2:1-13
131. Embrechts MJ, Arciniegas FA, Ozdemir M et al. (2001) Bagging neural network sensitivity analysis for feature reduction in QSAR problems. In: 2001 INNS-IEEE International Joint Conference on Neural Networks, IEEE Press, Washington, DC, pp 2478-2482 (Pubitemid 32804826)
132. Bakken GA, Jurs PC (2000) Classi fi cation of multidrug-resistance reversal agents using structure-based descriptors and linear discriminant analysis. J Med Chem 43:4534-4541 (Pubitemid 32046878)
133. Bennett K, Demiriz A (2000) Optimization approaches to semi-supervised learning. In: Ferris MC, Mangasarian OL, Pang JS (eds) Applications and algorithms of complementarity. Kluwer Academic, Boston
134. Burbidge R, Trotter M, Buxton B et al (2001) Drug design by machine learning: support vector machines for pharmaceutical data analysis. Comput Chem 26:5-14 (Pubitemid 33034554)
135. Czerminski R, Yasri A, Hartsough D (2001) Use of support vector machine in pattern classi fi cation: application to QSAR studies. QSAR 20:227-240 (Pubitemid 33051752)
136. Bennett KP, Embrechts MJ (2003) An optimization perspective on partial least squares. In: Suykens JAK, Horvath G, Basu S, Micchelli C, Vandewalle J (eds) Advances in learningtheory: methods, models and applications. IOS, Amsterdam, pp 227-250
137. Embrechts MJ, Robert Kewley J, Breneman C (1998) Computationally intelligent data mining for the automated design and discovery of novel pharmaceuticals. In: Dagli CH, Akay M, Buczak AL, Ersoy O, Fernandex BR (eds) Smart engineering systems: neural networks, fuzzy logic, evolutionary programming, data mining and rough sets, 1st edn. ASME, St. Louis, MO, pp 397-403 (Pubitemid 128724557)
138. Mazzatorta P, Benfenati E, Neagu D et al (2002) The importance of scaling in data mining for toxicity prediction. J Chem Inf Comput Sci 42:1250-1255 (Pubitemid 35369297)
139. Roy PP, Leonard JT, Roy K (2008) Exploring the impact of size of training sets for the development of predictive QSAR models. Chemometrics Intell Lab Syst 90:31-42 (Pubitemid 350213175)
140. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403-410, http://www.ncbi.nlm.nih.gov/ blast/
141. Nikolova N, Jaworska J (2003) Approaches to measure chemical similarity-a review. QSAR Comb Sci 22:1006-1026
142. Embrechts M, Breneman CM, Arciniegas F et al (2001) Data mining using 2-D neural network sensitivity analysis for molecules. In: Dagli CH (ed) Intelligent engineering systems through arti fi cial neural networks: smart engineering system design. ASME, New York, NY
143. Shao L, Wu L, Fan X et al (2010) Consensus ranking approach to understanding the underlying mechanism with QSAR. J Chem Inf Model 50:1941-1948
144. Swets JA, Dawes RM, Monahan J (2000) Better decisions through science. Sci Am 283:82-87
145. Fawcett T (2006) An introduction to ROC analysis. Pattern Recogn Lett 27:861-874